Madrid, September, 2019. Presbyopia is an age-related ocular condition that makes it hard to see objects located at near distance due to the loss of the accommodation capacity of the crystalline lens of the eye. Some of the alternatives to correct presbyopia include Intraocular and contact lenses (trifocal, bifocal, EDOF…), PresbyLasik, correcting one eye for far and another for distance (monovision), or correcting one eye for far and another with a multifocal lens (modified monovision). Scientists of the Institute of Optics have developed SimVis. This cutting edge technology was presented by the Spanish National Research Council (CSIC) last March in a press conference and allows patients for the first time to experience the real world through the different corrections available for presbyopia before prescription. The technique has been used in a study that compared the vision of patients with the different binocular alternatives previously mentioned and the results have been published in the prestigious magazine Plos One. According to Aiswaryah Radhakrishan, first author of the publication:
“Each patient shows a different preference for a particular combination of lenses, so that it is possible to select the optimal solution for every patient before prescribing a contact lens, or, more importantly, before implanting an intraocular lens.”
SimVis is commercialized by 2Eyes Vision, a spin-off company of the CSIC co-founded by Carlos Dorronsoro, Susana Marcos and the other authors of the publication. The technology will be commercially launched soon driven by the recent investment of Bullnet Capital (round closed in August 2019) and other relevant funds obtained from ERC Proof of Concept Grant SimVisSim, European Institute of Technology Health Accelerator, NEOTEC (CDTI), Horizon 2020, EIT Health, Doctorados Industriales (CAM) and Torres Quevedo (MICINN).
Citation: Radhakrishnan A, Pascual D, Marcos S, Dorronsoro C (2019) Vision with different presbyopia corrections simulated with a portable binocular visual simulator. PLoS ONE 14(8): e0221144. https://doi.org/10.1371/journal.pone.0221144
Moore information about the article: Carlos Dorronsoro (email@example.com)
More information about 2Eyes Vision: Álvaro Sánchez-Lozano (firstname.lastname@example.org)